GLP-1 for Weight Loss: How the Satiety Hormone Works and Why Mounjaro is More Effective Than Ozempic

Imagine your body has a built-in appetite regulator. It tells your brain when to stop eating, slows digestion, and keeps blood sugar in check. This regulator is called GLP-1. And it's become the foundation for a new generation of weight loss medications.

If you've heard of Mounjaro, Ozempic, or Wegovy, you've already encountered GLP-1 agonists. But what are they really? How do they work? And most importantly, which one is right for you?

What is GLP-1 and why do you need it?

GLP-1 stands for glucagon-like peptide-1. It's a hormone your intestines produce every time you eat.

What does GLP-1 do in a healthy body? It performs several important functions simultaneously. It signals fullness to the brain so you feel satisfied. It slows stomach emptying, so food digests longer. It stimulates insulin production when blood sugar rises. And it suppresses glucagon, which raises blood sugar.

That's why GLP-1 was first used to treat type 2 diabetes. Then researchers noticed that people on these medications lost significant weight. Thus a new direction in obesity medicine was born.

How does GLP-1 help with weight loss?

The weight loss mechanism with GLP-1 agonists is based on three key effects. And none of them require superhuman effort from you.

The first mechanism is the satiety signal to the brain. GLP-1 acts on the hypothalamus, the part of the brain that controls hunger. After a medication injection, you simply feel less desire to eat. Not through willpower, but physiologically.

The second mechanism is slowed digestion. Food stays in the stomach longer, so the feeling of fullness lasts longer. You eat smaller portions and don't think about snacking.

The third mechanism is reduced food 'reward'. GLP-1 affects pleasure centers in the brain. Cake or pizza no longer create such strong cravings. You're simply indifferent to what was once temptation.

Note the 'Mechanism' column. Mounjaro and Zepbound work on two receptors at once, GIP and GLP-1. This makes them more effective than drugs that only act on GLP-1.

You can read more details about each medication on the Mounjaro vs Ozempic comparison page.

Mounjaro: why is dual agonist more effective?

Mounjaro is the world's first dual GIP and GLP-1 agonist. Its active ingredient, tirzepatide, activates two hormonal pathways that control appetite and metabolism simultaneously.

The results were impressive. At 5 mg dose, participants lost an average of 16% weight. At 10 mg — 21.4%. And at the maximum 15 mg dose — a full 22.5% [3]. This means a person weighing 105 kg lost approximately 24 kg.

Even more interesting is the significant weight loss statistics. 63% of participants on the 15 mg dose lost over 20% of their weight [3]. For comparison, in the placebo group, only 1.3% achieved this result.

If you already have experience with Ozempic and want better results, switching to Mounjaro may be the next step. Read more about Ozempic for weight loss in our blog.

GLP-1 in tablets: when will injections disappear?

Many people fear injections. So questions about tablets are quite logical.

Rybelsus already exists — this is oral (tablet) semaglutide. It works, but has lower effectiveness than the injectable form. The reason is bioavailability — the stomach destroys part of the active ingredient.

Eli Lilly is developing oral tirzepatide. If they can preserve the effectiveness of the injectable form in a tablet, it will change the market forever.

For now, injections remain the gold standard. But they're not as scary as they seem. Modern KwikPen devices are nearly painless, and injection takes a few seconds once a week.

Side effects of GLP-1 medications: what to expect?

All GLP-1 agonists have similar side effect profiles. It's important to understand that most are mild and resolve on their own.

The most common reactions are nausea, diarrhea, or conversely constipation. They usually occur at the start of therapy and during dose increases. In the SURMOUNT-1 study, the percentage of treatment discontinuation due to side effects was 4.3-7.1% depending on dose [1]. This means over 90% of participants successfully continued therapy.

In the placebo group, the treatment discontinuation percentage was even higher at 26.4% [1]. This suggests that the medication's side effects are not as critical as they might seem.

How to choose the right GLP-1 medication?

The choice depends on several factors. Here's a simple algorithm to help you navigate.

If you need maximum results and are ready for the most advanced solution, choose Mounjaro. SURMOUNT-1 data clearly shows its advantage over single GLP-1 agonists [1] [3].

If you have experience with other weight loss medications, Mounjaro would also be a logical next step. It's suitable for those who previously used Ozempic with moderate results.

If you have type 2 diabetes, Mounjaro or Ozempic will work equally well. Both improve glycemic control and help with weight loss.

If budget is limited, compare prices on the cost page. Sometimes it's better to start with a lower dose and gradually increase.

Contact our specialist @Doza_sofia_bot on Telegram. Consultation is free and takes a few minutes.

What does this all mean for you?

GLP-1 agonists are not another diet fad. This is a scientifically proven approach to weight loss that works at the physiological level.

Research data speaks for itself. Mounjaro allows losing over one-fifth of body weight [1]. Ozempic and Wegovy show results around 15% [2]. New medications like Retatrutide promise even more.

The choice depends on your goals and circumstances. But one thing is certain — today you have access to tools that seemed like fantasy just ten years ago.

The first step to your desired figure is understanding what's right for you. A free consultation will help you understand the options and create a personalized plan.

Frequently asked questions about GLP-1 medications

Where to order Mounjaro in Ukraine

Ready to start the course? Buy Mounjaro in Ukraine is available in the DOZA catalog — all 6 doses (2.5, 5, 7.5, 10, 12.5, 15 mg) with official thermal delivery within 24 hours and 24/7 specialist support. Current Mounjaro prices 2026 — from 1,000 ₴ for a test dose or 8,000 ₴/month for a full program with monitoring.

Where to order DOZA products

DOZA supplies all products mentioned in the article with official cold chain and 24/7 specialist support. Choose what you need:

• Buy Ozempic in Ukraine — original semaglutide from Novo Nordisk with thermal delivery. Current Ozempic prices 2026 — from 1,600 ₴ for a starter dose.